» Articles » PMID: 32213600

Impact of 1,-ethenoadenosine, a Damaged Ribonucleotide in DNA, on Translesion Synthesis and Repair

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2020 Mar 28
PMID 32213600
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Incorporation of ribonucleotides into DNA can severely diminish genome integrity. However, how ribonucleotides instigate DNA damage is poorly understood. In DNA, they can promote replication stress and genomic instability and have been implicated in several diseases. We report here the impact of the ribonucleotide rATP and of its naturally occurring damaged analog 1,-ethenoadenosine (1,-ϵrA) on translesion synthesis (TLS), mediated by human DNA polymerase η (hpol η), and on RNase H2-mediated incision. Mass spectral analysis revealed that 1,-ϵrA in DNA generates extensive frameshifts during TLS, which can lead to genomic instability. Moreover, steady-state kinetic analysis of the TLS process indicated that deoxypurines ( dATP and dGTP) are inserted predominantly opposite 1,-ϵrA. We also show that hpol η acts as a reverse transcriptase in the presence of damaged ribonucleotide 1,-ϵrA but has poor RNA primer extension activities. Steady-state kinetic analysis of reverse transcription and RNA primer extension showed that hpol η favors the addition of dATP and dGTP opposite 1,-ϵrA. We also found that RNase H2 recognizes 1,-ϵrA but has limited incision activity across from this lesion, which can lead to the persistence of this detrimental DNA adduct. We conclude that the damaged and unrepaired ribonucleotide 1,-ϵrA in DNA exhibits mutagenic potential and can also alter the reading frame in an mRNA transcript because 1,-ϵrA is incompletely incised by RNase H2.

Citing Articles

AUF1 Recognizes 8-Oxo-Guanosine Embedded in DNA and Stimulates APE1 Endoribonuclease Activity.

Malfatti M, Codrich M, Dalla E, DAmbrosio C, Storici F, Scaloni A Antioxid Redox Signal. 2023; 39(7-9):411-431.

PMID: 36855946 PMC: 10517317. DOI: 10.1089/ars.2022.0105.


DNA polymerases η and κ bypass N-guanine-O-alkylguanine DNA alkyltransferase cross-linked DNA-peptides.

Ghodke P, Guengerich F J Biol Chem. 2021; 297(4):101124.

PMID: 34461101 PMC: 8463853. DOI: 10.1016/j.jbc.2021.101124.


Etheno adducts: from tRNA modifications to DNA adducts and back to miscoding ribonucleotides.

Guengerich F, Ghodke P Genes Environ. 2021; 43(1):24.

PMID: 34130743 PMC: 8207595. DOI: 10.1186/s41021-021-00199-x.


Enzymatic bypass and the structural basis of miscoding opposite the DNA adduct 1,N-ethenodeoxyguanosine by human DNA translesion polymerase η.

Ghodke P, Mali J, Patra A, Rizzo C, Guengerich F, Egli M J Biol Chem. 2021; 296:100642.

PMID: 33839151 PMC: 8121704. DOI: 10.1016/j.jbc.2021.100642.


Enzymatic bypass of an N-deoxyadenosine DNA-ethylene dibromide-peptide cross-link by translesion DNA polymerases.

Ghodke P, Gonzalez-Vasquez G, Wang H, Johnson K, Sedgeman C, Guengerich F J Biol Chem. 2021; 296:100444.

PMID: 33617883 PMC: 8024977. DOI: 10.1016/j.jbc.2021.100444.

References
1.
Acharya N, Manohar K, Peroumal D, Khandagale P, Patel S, Sahu S . Multifaceted activities of DNA polymerase η: beyond translesion DNA synthesis. Curr Genet. 2018; 65(3):649-656. DOI: 10.1007/s00294-018-0918-5. View

2.
Kim N, Cho J, Li Y, Jinks-Robertson S . RNA∶DNA hybrids initiate quasi-palindrome-associated mutations in highly transcribed yeast DNA. PLoS Genet. 2013; 9(11):e1003924. PMC: 3820800. DOI: 10.1371/journal.pgen.1003924. View

3.
Markkanen E . Not breathing is not an option: How to deal with oxidative DNA damage. DNA Repair (Amst). 2017; 59:82-105. DOI: 10.1016/j.dnarep.2017.09.007. View

4.
Storici F, Bebenek K, Kunkel T, Gordenin D, Resnick M . RNA-templated DNA repair. Nature. 2007; 447(7142):338-41. PMC: 2121219. DOI: 10.1038/nature05720. View

5.
Sastre-Moreno G, Sanchez A, Esteban V, Blanco L . ATP insertion opposite 8-oxo-deoxyguanosine by Pol4 mediates error-free tolerance in Schizosaccharomyces pombe. Nucleic Acids Res. 2014; 42(15):9821-37. PMC: 4150805. DOI: 10.1093/nar/gku711. View